Would you like to know how many people have visited this page? Or how reputable the author is? Simply
sign up for a Advocate premium membership and you'll automatically see this data on every article. Plus a lot more, too.
 SHARE 
|
|
OpEd News Member for 940 week(s) and 3 day(s)
40 Articles, 0 Quick Links, 2 Comments, 0 Diaries, 0 Polls
Articles Listed By Date
List By Popularity
List By Popularity
Page 1 of 2 First Last Back Next 2 View All
(1 comments) SHARE
Saturday, May 10, 2008
Suicide: "An exit strategy" for doctors The American Medical Association has called physician suicide "an endemic catastrophe."
Saturday, May 10, 2008Suicide: "An exit strategy" for doctors The American Medical Association has called physician suicide "an endemic catastrophe."
SHARE
Friday, August 24, 2007
Pfizer should buy Wyeth. Here's why Due to a raft of upcoming patent expirations, the future is bleak for Pfizer. Among others, Pfizer will lose the blockbuster Lipitor, as early as 2010. Lipitor generated 2006 revenues of $13.6 billion, which was 28% of Pfizer's $48 billion in revenues.
Friday, August 24, 2007Pfizer should buy Wyeth. Here's why Due to a raft of upcoming patent expirations, the future is bleak for Pfizer. Among others, Pfizer will lose the blockbuster Lipitor, as early as 2010. Lipitor generated 2006 revenues of $13.6 billion, which was 28% of Pfizer's $48 billion in revenues.
SHARE
Thursday, August 9, 2007
Drug companies cooperated with the CIA. THE CIA on June 26, 2007 declassified secret documents that revealed "the Agency had relations with commercial drug manufacturers, whereby they passed on drugs rejected because of unfavorable side effects."
Thursday, August 9, 2007Drug companies cooperated with the CIA. THE CIA on June 26, 2007 declassified secret documents that revealed "the Agency had relations with commercial drug manufacturers, whereby they passed on drugs rejected because of unfavorable side effects."
SHARE
Monday, August 6, 2007
A new HIV drug from Pfizer was approved today - shortly after three HIV executives were terminated. Pfizer Inc announced in a press release today that the U.S. Food and Drug Administration has approved SelzentryTM (maraviroc) tablets, the first in a new class of oral HIV medicines in more than 10 years. But how did this approval come about?
Monday, August 6, 2007A new HIV drug from Pfizer was approved today - shortly after three HIV executives were terminated. Pfizer Inc announced in a press release today that the U.S. Food and Drug Administration has approved SelzentryTM (maraviroc) tablets, the first in a new class of oral HIV medicines in more than 10 years. But how did this approval come about?
SHARE
Wednesday, August 1, 2007
Brandweek creates media history, hires blogger to replace journalist. And yes, the rumors are true, that blogger is me. I'll start to write for BrandweekNRX today. Assist with a daily column, for a while.
Wednesday, August 1, 2007Brandweek creates media history, hires blogger to replace journalist. And yes, the rumors are true, that blogger is me. I'll start to write for BrandweekNRX today. Assist with a daily column, for a while.
SHARE
Tuesday, July 24, 2007
Pfizer's "Viva Viagra" ad drives AIDS activists nuts Pfizer sales of Viagra have hit rock bottom. So Pfizer Inc would like to make sure more men get rock hard. And regular pharmaceutical advertising ain't cutting it no more. You know - - dogs, happy couples holding hands.
Tuesday, July 24, 2007Pfizer's "Viva Viagra" ad drives AIDS activists nuts Pfizer sales of Viagra have hit rock bottom. So Pfizer Inc would like to make sure more men get rock hard. And regular pharmaceutical advertising ain't cutting it no more. You know - - dogs, happy couples holding hands.
SHARE
Thursday, July 19, 2007
Novartis Fired Whistleblower Who Then Met With FDA: Cancer Drug Approval Delayed According to a lawsuit Olagunju filed in May 2007, Novartis fired Olagunju for "disclosing and refusing to participate in illegal and unethical activities regarding the testing and reporting of human drug study results concerning Tasigna (ANM), Novartis' new cancer drug."
Thursday, July 19, 2007Novartis Fired Whistleblower Who Then Met With FDA: Cancer Drug Approval Delayed According to a lawsuit Olagunju filed in May 2007, Novartis fired Olagunju for "disclosing and refusing to participate in illegal and unethical activities regarding the testing and reporting of human drug study results concerning Tasigna (ANM), Novartis' new cancer drug."
(1 comments) SHARE
Wednesday, July 18, 2007
Pfizer profit down 48%, but lets put some lipstick on that pig! How Pfizer puts some spin on terrible numbers.
Wednesday, July 18, 2007Pfizer profit down 48%, but lets put some lipstick on that pig! How Pfizer puts some spin on terrible numbers.
(2 comments) SHARE
Monday, July 16, 2007
Senior Pfizer executive condemns drug advertising in newspapers and on television!
Monday, July 16, 2007Senior Pfizer executive condemns drug advertising in newspapers and on television!
SHARE
Thursday, June 21, 2007
Pfizer risked HIV drug approval "to make it a little harder" for plaintiff's lawyers. According to the WSJ today, "Pfizer Inc.'s pipeline was dealt a surprise blow last night, when the FDA delayed the approval of one of its most interesting drug prospects, a new type of medicine for HIV."
Thursday, June 21, 2007Pfizer risked HIV drug approval "to make it a little harder" for plaintiff's lawyers. According to the WSJ today, "Pfizer Inc.'s pipeline was dealt a surprise blow last night, when the FDA delayed the approval of one of its most interesting drug prospects, a new type of medicine for HIV."
SHARE
Thursday, June 21, 2007
Did Pfizer's maraviroc whistleblower delay FDA approval of HIV drug? Did the allegations related to illegal premarketing of maraviroc result in delayed FDA approval?
Thursday, June 21, 2007Did Pfizer's maraviroc whistleblower delay FDA approval of HIV drug? Did the allegations related to illegal premarketing of maraviroc result in delayed FDA approval?
SHARE
Thursday, June 21, 2007
Monogram Biosciences stock: Panic selling after news of delayed Pfizer HIV drug
Thursday, June 21, 2007Monogram Biosciences stock: Panic selling after news of delayed Pfizer HIV drug
(1 comments) SHARE
Monday, June 11, 2007
Pfizer screws up royally: 17,000 employee names and SS numbers copied by thieves According to Pfizer, "the breach occurred when the spouse of a Pfizer employee loaded unauthorized software onto the employee's Pfizer laptop computer. The software allowed outsiders access to a number of files, that included the names and social security numbers of the affected Pfizer employees."
Monday, June 11, 2007Pfizer screws up royally: 17,000 employee names and SS numbers copied by thieves According to Pfizer, "the breach occurred when the spouse of a Pfizer employee loaded unauthorized software onto the employee's Pfizer laptop computer. The software allowed outsiders access to a number of files, that included the names and social security numbers of the affected Pfizer employees."
SHARE
Wednesday, May 23, 2007
Pfizer's "Delete! Delete!" memo: "Do NOT forward or retain this e-mail . . ."
Wednesday, May 23, 2007Pfizer's "Delete! Delete!" memo: "Do NOT forward or retain this e-mail . . ."
SHARE
Tuesday, May 22, 2007
Pfizer sales rep: "PFE tried to find 'naïve doctors' for illegal premarketing of maraviroc!" A Pfizer whistleblower a few weeks ago alleged that Pfizer used the HIV sales force to illegally market maraviroc to doctors before FDA approval. The illegal conduct allegedly started already in November 2006, when Pfizer was trying to set up "expanded access sites" throughout the country for a maraviroc experience trial.
Tuesday, May 22, 2007Pfizer sales rep: "PFE tried to find 'naïve doctors' for illegal premarketing of maraviroc!" A Pfizer whistleblower a few weeks ago alleged that Pfizer used the HIV sales force to illegally market maraviroc to doctors before FDA approval. The illegal conduct allegedly started already in November 2006, when Pfizer was trying to set up "expanded access sites" throughout the country for a maraviroc experience trial.
SHARE
Sunday, May 20, 2007
PFIZER CFO RESIGNS after PFE finance executive blows the whistle. Pfizer CFO Mr. Levin's resignation comes after three days of disclosures of corruption in Pfizer's finance department, revealed by former Pfizer finance executive Mr. Ashok S. Idnani.
Sunday, May 20, 2007PFIZER CFO RESIGNS after PFE finance executive blows the whistle. Pfizer CFO Mr. Levin's resignation comes after three days of disclosures of corruption in Pfizer's finance department, revealed by former Pfizer finance executive Mr. Ashok S. Idnani.
SHARE
Tuesday, May 1, 2007
OIG REQUESTS MEETING WITH PFIZER HIV WHISTLEBLOWER. The Pfizer whistleblower in my story "Pfizer whistleblower accuses company of using sales force to illegally market new AIDS-drug before FDA approval" has just forwarded the response she received from an agent
Tuesday, May 1, 2007OIG REQUESTS MEETING WITH PFIZER HIV WHISTLEBLOWER. The Pfizer whistleblower in my story "Pfizer whistleblower accuses company of using sales force to illegally market new AIDS-drug before FDA approval" has just forwarded the response she received from an agent
